SIRT3 and breast carcinoma: In this regard, the mice lacking Sirt3 appear to be an new in vivo model to investigate the connection between aging and carcinogenesis since these mice, at ages greater than 13 months, developed well differentiated ER/PR receptor positive mammary tumors, which is the subtype of breast cancer that is most commonly observed in postmenopausal women [18].